Medicure appoints Kerrie Hayes to board as director Peter Quick steps down

  • Medicure added Kerrie Hayes as an independent director, expanding its board to five members.
  • Hayes is director of research contracts at the University of Manitoba, previously served as Medicure’s director of business development, previously worked as an intellectual property manager at a life sciences incubator.
  • Peter Quick stepped down from the board at the annual shareholder meeting.
  • Shareholders elected Dr. Albert Friesen, Dr. Arnold Naimark, James Kinley, Brent Fawkes, and Hayes as directors.
  • 5,237,796 shares were voted, representing 50.19% of outstanding shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicure Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202605211700ACCESSWRNAPR_____1169436) on May 21, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.